[HTML][HTML] Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients
…, R Centis, ED Chan, CY Chiang, H Cox, L D'Ambrosio… - 2012 - journals.plos.org
Background Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic,
expensive, and has generally poor outcomes. We undertook an individual patient data meta-…
expensive, and has generally poor outcomes. We undertook an individual patient data meta-…
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases
…, R Centis, L d'Ambrosio… - European …, 2020 - Eur Respiratory Soc
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19)
pandemic has attracted interest because of its global rapid spread, clinical severity, high …
pandemic has attracted interest because of its global rapid spread, clinical severity, high …
Towards tuberculosis elimination: an action framework for low-incidence countries
…, GB Migliori, I Abubakar, L D'Ambrosio… - European …, 2015 - Eur Respiratory Soc
This paper describes an action framework for countries with low tuberculosis (TB) incidence
(<100 TB cases per million population) that are striving for TB elimination. The framework …
(<100 TB cases per million population) that are striving for TB elimination. The framework …
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
…, M Charles, A Cirule, MP Dalcolmo, L d'Ambrosio… - The Lancet, 2018 - thelancet.com
Background Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed
to estimate the association of treatment success and death with the use of individual drugs, …
to estimate the association of treatment success and death with the use of individual drugs, …
[HTML][HTML] Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects
Evidence is accumulating on the interaction between tuberculosis (TB) and COVID-19. The
aim of the present review is to report the available evidence on the interaction between these …
aim of the present review is to report the available evidence on the interaction between these …
Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients
…, L Ferrucci, M Franceschi, LP D'Ambrosio… - Rejuvenation …, 2008 - liebertpub.com
Our objective was to construct and validate a Multidimensional Prognostic Index (MPI) for 1-year
mortality from a Comprehensive Geriatric Assessment (CGA) routinely carried out in …
mortality from a Comprehensive Geriatric Assessment (CGA) routinely carried out in …
Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus
A Grifa, CA Wagner, L D'Ambrosio, S Melchionda… - Nature …, 1999 - nature.com
correspondence 16 nature genetics• volume 23• september 1999 light of speculation that
some form of DNA rearrangement is involved during the selective expression of individual …
some form of DNA rearrangement is involved during the selective expression of individual …
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR-and XDR-TB: a multicentre study
…, M Enwerem, RR Leyet, L D'Ambrosio… - European …, 2017 - Eur Respiratory Soc
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant
tuberculosis (XDR-TB) are lacking. This study aimed to evaluate the safety and …
tuberculosis (XDR-TB) are lacking. This study aimed to evaluate the safety and …
Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes
…, K DeRiemer, R Centis, L D'Ambrosio… - European …, 2013 - Eur Respiratory Soc
A meta-analysis for response to treatment was undertaken using individual data of multidrug-resistant
tuberculosis (MDR-TB) (resistance to isoniazid and rifampicin) patients from 26 …
tuberculosis (MDR-TB) (resistance to isoniazid and rifampicin) patients from 26 …
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis
G Sotgiu, R Centis, L D'Ambrosio… - European …, 2012 - Eur Respiratory Soc
Linezolid is used off-label to treat multidrug-resistant tuberculosis (MDR-TB) in absence of
systematic evidence. We performed a systematic review and meta-analysis on efficacy, safety …
systematic evidence. We performed a systematic review and meta-analysis on efficacy, safety …